Rare diseases
Investigational molecules
Locations
Back to Italy987 clinical trials in Candiolo, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of cannabidiol (CardiolRx) in patients with recurrent pericarditis after stopping IL-1 blocker treatment
ItalyStudy on Long-Term Effects of Efanesoctocog Alfa in Preventing Joint Bleeds in Patients with Hemophilia A
ItalyStudy for Adults with Chronic Myeloid Leukemia Using Asciminib Alone or with Nilotinib
ItalyStudy on the Safety and Effectiveness of CSL889 for Adults and Adolescents with Sickle Cell Disease During Painful Crises
ItalyStudy on the Effectiveness and Safety of Finerenone for Patients with Chronic Kidney Disease and Type 1 Diabetes
ItalyStudy on the Safety and Effectiveness of Vorasidenib and Temozolomide for Patients with IDH1 or IDH2 Mutant Glioma
ItalyStudy on Electrochemotherapy with Bleomycin for Patients with Recurrent Oral and Oropharyngeal Cancer
ItalyStudy on the Effectiveness of Optune with Temozolomide and Pembrolizumab in Patients with Newly Diagnosed Glioblastoma
ItalyStudy of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease
ItalyStudy Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments
ItalyStudy of Ruxolitinib with Brentuximab or Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
ItalyStudy on Chemotherapy and Aromatase Inhibitors (Exemestane, Letrozole, Anastrozole) for Post-Menopausal Patients with Early Breast Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Advanced research focusing on blood cancers including innovative treatments for myelodysplastic syndromes, follicular lymphoma, and chronic myelomonocytic leukemia. Studies evaluate novel drug combinations and maintenance therapies to improve patient outcomes.
Trials investigate targeted therapies and immunotherapy approaches for better disease management.
Comprehensive research on lung cancer, breast cancer, and colorectal cancer. Studies explore combination therapies involving immunotherapy, targeted agents, and conventional treatments to enhance treatment efficacy.
Focus on personalized medicine approaches and biomarker-driven treatment selection.
Dedicated research into sarcomas, head and neck cancers, and other rare malignancies. Studies evaluate novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Emphasis on developing effective treatments for cancers with limited therapeutic options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
